Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Pharmakon Advisors
AddedFeb 13, 2024
UpdatedJun 28, 2026
Pharmakon Advisors

Pharmakon Advisors

Operating

Pharmakon Advisors, LP: Investment and financial planning solutions provider.

Location
New York City, NY, US
Founded
2009
Firm
Compare
Portfolio
Fundraising
Employees
Website

Pharmakon Advisors specializes in providing debt capital to the life sciences industry through BioPharma Credit PLC, a closed-end investment trust. The firm focuses on offering financing solutions to pharmaceutical and biotechnology companies, typically in the form of post-IPO debt and other debt financing structures. Their investments range from $23 million to $575 million, with a particular emphasis on larger deals.

The firm's portfolio includes notable companies such as Akebia Therapeutics, BioCryst Pharmaceuticals, Coherus BioSciences, and Sarepta Therapeutics. Pharmakon Advisors' investment strategy targets established companies in the life sciences sector, providing them with the necessary capital to advance their research, development, and commercialization efforts. Their unique approach offers an alternative funding source for biotech and pharma companies seeking to accelerate growth without diluting equity.

Pharmakon Advisors - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments12
Current Portfolio Count12
Total Portfolio Exits0

Top Investment Stages

Post Ipo Debt10 (83.3%)
Debt Financing1 (8.3%)
Series A1 (8.3%)

Stage Mix

Post Ipo Debt 83%Debt Financing 8%Series A 8%

Concentration shown as share of disclosed investments by stage.

Recent Investments

BioCryst Pharmaceuticals logo

BioCryst Pharmaceuticals

Insmed logo

Insmed

UroGen Pharma logo

UroGen Pharma

Coherus BioSciences logo

Coherus BioSciences

Evolus logo

Evolus

Brainbox Solutions logo

Brainbox Solutions

Sarepta Therapeutics logo

Sarepta Therapeutics

Akebia Therapeutics logo

Akebia Therapeutics

Novocure logo

Novocure

Halozyme Therapeutics logo

Halozyme Therapeutics

Assertio Holdings logo

Assertio Holdings

PaxVax logo

PaxVax

Pharmakon Advisors - Similar Investment Firms

Apothecary Capital logo

Apothecary Capital

apothcap.com

PharmaBio Investments logo

PharmaBio Investments

Partners for Growth logo

Partners for Growth

pfgrowth.com

Bain Capital Life Sciences logo

Bain Capital Life Sciences

baincapital.com

Fairmount Funds Management logo

Fairmount Funds Management

fairmountfunds.com

Perceptive Advisors logo

Perceptive Advisors

perceptivelife.com

Park Cities Advisors logo

Park Cities Advisors

parkcitiesmgmt.com

Life Sciences Alternative Funding logo

Life Sciences Alternative Funding

lsafunding.com

Princeton Biopharma Capital Partners logo

Princeton Biopharma Capital Partners

princetonbcp.com

Ra Capital Management logo

Ra Capital Management

racap.com

BioImpact Capital logo

BioImpact Capital

Acorn Bioventures logo

Acorn Bioventures

Mirae Asset Capital Life Science logo

Mirae Asset Capital Life Science

Paramount Biocapital Asset Management logo

Paramount Biocapital Asset Management

Inbio Ventures logo

Inbio Ventures

Pharmakon Advisors - Classification

Also Known As
  • Pharmakon Advisors, LP
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 2 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
SIC
  • 6000Depository Institutions